Skip to main content
Main menu
HOME
ONLINE FIRST
CURRENT ISSUE
ALL ISSUES
AUTHORS & REVIEWERS
SUBSCRIBE
CONFERENCE
MORE
About BJGP
Advertising
eLetters
Alerts
BJGP LIFE
Video
Audio
Librarian information
Resilience
COVID-19 Clinical Solutions
RCGP
BJGP for RCGP members
BJGP Open
RCGP eLearning
InnovAIT Journal
Jobs and careers
User menu
Subscriptions
Alerts
Log in
Search
Search for this keyword
Advanced search
Intended for Healthcare Professionals
RCGP
BJGP for RCGP members
BJGP Open
RCGP eLearning
InnovAIT Journal
Jobs and careers
Subscriptions
Alerts
Log in
Follow BJGP on LinkedIn
Follow bjgp on BlueSky
Visit bjgp on Facebook
Blog
Listen to BJGP podcast
Subscribe BJGP on YouTube
Visit bjgp on Instagram
Intended for Healthcare Professionals
Search for this keyword
Advanced Search
HOME
ONLINE FIRST
CURRENT ISSUE
ALL ISSUES
AUTHORS & REVIEWERS
SUBSCRIBE
CONFERENCE
MORE
About BJGP
Advertising
eLetters
Alerts
BJGP LIFE
Video
Audio
Librarian information
Resilience
COVID-19 Clinical Solutions
C-reactive protein
Point-of-care biomarkers or laboratory-based tests to reduce antibiotic prescribing for COPD exacerbations: a literature review and meta-analysis in primary care
Mathieu
Frénois
, et al
British Journal of General Practice
30 July 2026;
76
(769):
e681-e692.
DOI:
https://doi.org/10.3399/BJGP.2025.0593
Implementing antibiotic stewardship in high-prescribing English general practices: a mixed-methods study
Sarah
Tonkin-Crine
, et al
British Journal of General Practice
23 February 2023;
73
(728):
e164-e175.
DOI:
https://doi.org/10.3399/BJGP.2022.0298
Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial
David
Gillespie
, et al
British Journal of General Practice
26 March 2021;
71
(705):
e266-e272.
DOI:
https://doi.org/10.3399/BJGP.2020.0823
C-reactive protein-guided antibiotic prescribing for COPD exacerbations: a qualitative evaluation
Rhiannon
Phillips
, et al
British Journal of General Practice
25 June 2020;
70
(696):
e505-e513.
DOI:
https://doi.org/10.3399/bjgp20X709865
Use of multiple inflammatory marker tests in primary care: using Clinical Practice Research Datalink to evaluate accuracy
Jessica
Watson
, et al
British Journal of General Practice
27 June 2019;
69
(684):
e462-e469.
DOI:
https://doi.org/10.3399/bjgp19X704309
‘I’m fishing really’ — inflammatory marker testing in primary care: a qualitative study
Jessica
Watson
, et al
British Journal of General Practice
25 February 2016;
66
(644):
e200-e206.
DOI:
https://doi.org/10.3399/bjgp16X683857
Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions
Raymond
Oppong
, et al
British Journal of General Practice
1 July 2013;
63
(612):
e465-e471.
DOI:
https://doi.org/10.3399/bjgp13X669185
Antibiotic prescribing and C-reactive protein testing for pulmonary infections in patients with intellectual disabilities
Catharina M
Peters
, et al
British Journal of General Practice
1 May 2013;
63
(610):
e326-e330.
DOI:
https://doi.org/10.3399/bjgp13X667187
Accuracy of symptoms, signs, and C-reactive protein for early chronic obstructive pulmonary disease
Berna DL
Broekhuizen
, et al
British Journal of General Practice
1 September 2012;
62
(602):
e632-e638.
DOI:
https://doi.org/10.3399/bjgp12X654605
Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care
Anette
Holm
, et al
British Journal of General Practice
1 July 2007;
57
(540):
555-560.
Pages
Next
1
2
